Senseonics Holdings (SENS) EBITDA Margin (2015 - 2026)
Senseonics Holdings (SENS) reported EBITDA Margin of 276.61% for Q1 2026, down 4868.0% year-over-year from 5.8% in Q1 2025, and down 89.2% quarter-over-quarter from 146.2% in Q4 2025.
Senseonics Holdings (SENS) EBITDA Margin (2015 - 2026) Analysis & Trends
Senseonics Holdings (SENS) has 12 years of EBITDA Margin data on file, last reported at 276.61% in Q1 2026.
- EBITDA Margin for Q1 2026 came in at 276.61%, down 4868.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 214.13% (up 9834.0% YoY), and the FY2025 annual result was 195.83%, up 15396.0% from the prior year.
- EBITDA Margin slipped to 276.61% in Q1 2026 per SENS's latest filing, from 146.2% in the prior quarter.
- Over five years, EBITDA Margin peaked at 75868.61% in Q2 2022 and troughed at 1307.83% in Q3 2022.
- A 5-year average of 5915.05% and a median of 227.94% in 2025 frame the typical range for EBITDA Margin.
- The sharpest annual moves came in 2022 and 2023: EBITDA Margin soared 11751342 bps in 2022, then slumped 7636117 bps in 2023.
- A 5-year view of EBITDA Margin shows it stood at 216.62% in 2022, then tumbled by 199 bps to 213.47% in 2023, then advanced by 12 bps to 186.94% in 2024, then climbed by 22 bps to 146.2% in 2025, then plunged by 89 bps to 276.61% in 2026.
- Business Quant data shows SENS's EBITDA Margin at 276.61% in Q1 2026, 146.2% in Q4 2025, and 240.46% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | Senseonics Holdings | 309.99 Mn | 245.67 Mn | 6.94 Mn | -276.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -276.61% |
| Dec 31, 2025 | -146.20% |
| Sep 30, 2025 | -240.46% |
| Jun 30, 2025 | -217.70% |
| Mar 31, 2025 | -227.94% |
| Dec 31, 2024 | -186.94% |
| Sep 30, 2024 | -561.46% |
| Jun 30, 2024 | -417.10% |
| Mar 31, 2024 | -373.85% |
| Dec 31, 2023 | -213.47% |
| Sep 30, 2023 | -394.33% |
| Jun 30, 2023 | -492.56% |
| Mar 31, 2023 | 43.07% |
| Dec 31, 2022 | 216.62% |
| Sep 30, 2022 | -1,307.83% |
| Jun 30, 2022 | 75,868.61% |
| Mar 31, 2022 | 29,483.90% |
| Dec 31, 2021 | 674.89% |
| Sep 30, 2021 | 15,555.07% |
| Jun 30, 2021 | -41,644.80% |